[1]
Wang X., Wang YQ., Chen ZG., Shin DM., Advances of Cancer Therapy by Nanotechnology. Cancer Res Treat. 41(1) (2009), 1-11.
Google Scholar
[2]
Medina C., Santos-Martinez MJ., Radomski A., Corrigan OI., Radomski MW., Nanoparticles: pharmacological and toxicological significance. British Journal of Pharmacology. 150(5) (2007), 552–558.
DOI: 10.1038/sj.bjp.0707130
Google Scholar
[3]
Zhang Y., Zhuo RX., Synthesis,characterization,and in vitro 5-fu release behavior of oly(2,2-dimethyltrimethylenecarbonate)-poly(ethyleneglycol)-poly(2,2-dimethyltrimethylenecarbonate) nanoparticles. Journal of Biomedical Materials Research. 76(4) (2006), 674-680.
DOI: 10.1002/jbm.a.30395
Google Scholar
[4]
Nair KL., Jagadeeshan S., Nair SA., Kumar GS., Biological evaluation of 5-fuorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA. International Journal of Nanomedicine. 6(2011)1685-1697.
DOI: 10.2147/ijn.s20165
Google Scholar
[5]
You J., Liu YC., Peng CA., Effcient gene transfection using chitosan–alginate core-shell nanoparticles. International Journal of nanomedicine. 1(2) (2006)-180.
DOI: 10.2147/nano.2006.1.2.173
Google Scholar
[6]
Hartig SM., Greene RR., Dasgupta J., Carlesso G., Dikov MM., Prokop A., Davidson JM., Multifunctional Nanoparticulate Polyelectrolyte Complexes. Pharmaceutical Research. 24(12) (2007) 98-2206.
DOI: 10.1007/s11095-008-9623-2
Google Scholar
[7]
Nagpal K., Singh SK., Mishra DN., Chitosan Nanoparticles: A Promising System in Novel Drug Delivery. Chem. Pharm. Bull. 58(11) (2010) 3-1430.
DOI: 10.1248/cpb.58.1423
Google Scholar
[8]
Hamman JH., Chitosan Based Polyelectrolyte Complexes as Potential Carrier Materials in Drug Delivery Systems. Mar. Drugs. 8(2010) 305-1322.
DOI: 10.3390/md8041305
Google Scholar
[9]
Ahmad Z., Khuller GK., Alginate-based sustained release drug delivery systems for tuberculosis. Expert Opin Drug Deliv. 5(12) (2008) 23-34.
DOI: 10.1517/17425240802600662
Google Scholar
[10]
Reis CP., Neufeld RJ., Vilela S., Ribeiro AJ., Veiga F., Review and current status of emulsion/dispersion technology using an internal gelation process for the design of alginate particles. J Microencapsul. 23(3) (2006) 5-57.
DOI: 10.1080/02652040500286086
Google Scholar
[11]
Grem JL., 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development. Invest New Drugs. 18(4) (2000) -313.
DOI: 10.1023/a:1006416410198
Google Scholar
[12]
Llorca FC., Esquerdo GG., Cervera GJ., Gervera GJM., Briceno GHC., Calduch BJV., Delpino CJ., 5-Fluorouracil-induced small bowel toxicity in a patient with colorectal cancer. Clin Transl Oncol. 7(8) (2005) 6-357.
Google Scholar